Sanderling Venture Partners V, LP

This profile gathers the share dealings of Sanderling Venture Partners V, LP across 2 companies, led by Chimerix Inc and Endocyte Inc. Between 4 February 2011 and 12 September 2014, the trades on record add up to 44 filings.

The open-market side counts 5 purchases for €5.5M alongside 1 sale for €2.8M. The net balance comes to €2.7M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2014 alone, the filings show no purchases and 1 sale.

In size, the median ticket on the buying side is €526k.

The record was last updated on 16 September 2014 with a transaction in Chimerix Inc. The most recent open-market purchase was published on 11 January 2012, 5,416 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.